Virginia Tech: Hard-to-treat Cancers Respond to Combination Therapy Using Class of Drugs
July 26, 2025
July 26, 2025
BLACKSBURG, Virginia, July 26 (TNSjou) -- Virginia Tech issued the following news:
* * *
Hard-to-treat cancers respond to combination therapy using a new class of drugs
In a powerful new approach, Fralin Biomedical Research Institute scientists use advanced gene editing to study potential dual therapy for lung, brain, and pancreatic cancers.
By Leigh Anne Kelley
A potential target for experimental drugs that block PRMT5 -- a natur . . .
* * *
Hard-to-treat cancers respond to combination therapy using a new class of drugs
In a powerful new approach, Fralin Biomedical Research Institute scientists use advanced gene editing to study potential dual therapy for lung, brain, and pancreatic cancers.
By Leigh Anne Kelley
A potential target for experimental drugs that block PRMT5 -- a natur . . .